Immunofluorescence (IF) staining demonstrated that treatment with BAPN or LOX-neutralizing antibodies in tumor-bearing C57BL/6J mice increased intratumoral CD8+ T cells (Supplemental Figure 1, D–I) and activated CD8+ (CD8+CD69+) T cells (Figure 1, E and F). The gene discussed is CD8A; the disease is neoplasm.